Dr Bauml On The Use Of Immunotherapy In Oligometastatic Nsclc

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the use of immunotherapy in oligometastatic non–small cell lung cancer.

  • Dr. Bauml on the Use of Immunotherapy in Oligometastatic NSCLC ( Download)
  • Dr. Bauml on Treatment For Oligometastatic NSCLC ( Download)
  • Dr. Bauml on Locally Ablative Therapy in Oligometastatic NSCLC ( Download)
  • Pembrolizumab as Treatment for Oligometastatic NSCLC ( Download)
  • Dr. Bauml on Immunotherapy Combinations in Head and Neck Cancer ( Download)
  • Dr. Bauml on Emerging Biomarkers in NSCLC ( Download)
  • Dr. Bauml Discusses Immunotherapy in Head and Neck Cancer ( Download)
  • Immunotherapy in lung cancer: Panacea vs. reality ( Download)
  • Dr. Urbanic on the Role of Radiotherapy in Oligometastatic NSCLC ( Download)
  • Dr. Bauml on a New Platform to Enhance Lung Cancer Clinical Trial Enrollment ( Download)
  • World Cancer Day with Dr. Bauml ( Download)
  • Dr. Joshua M. Bauml on the Impact of Pembrolizumab in Head and Neck Cancer ( Download)
  • Dr. Joshua M. Bauml on Pembrolizumab Versus Chemo in Head and Neck Cancers ( Download)
  • Lung Cancer Video Library 2020 - BAUML - Emerging Molecular Targets in NSCLC, RET Fusions ( Download)
  • Expanding beyond the checkpoints: New vaccines and other immunologic strategies for NSCLC ( Download)

Author

Ariyani

Como educador, estou profundamente engajado no desenvolvimento dos estudantes em ambiente escolar, adotando métodos pedagógicos que valorizam conexões genuínas e são movidos por inovação e fervor. É minha vocação guiar os alunos na jornada de se tornarem uma geração notável, empregando estratégias de ensino amplamente aclamadas por prestigiadas instituições acadêmicas ao redor do globo - events.zulekhahospitals.com